Hofmann Thomas W
CIK: 0001174597
Associated companies
Transaction History
| WST | ▲ Buy | Grant | 1,071 | $0 | 5/6/2025 | View on chart |
| WST | ▼ Sell | Open Market | 617 | $226K | 5/10/2024 | View on chart |
| WST | ▲ Buy | Grant | 564 | $0 | 4/23/2024 | View on chart |
| WST | ▼ Sell | Open Market | 1,212 | $443K | 5/1/2023 | View on chart |
| WST | ▲ Buy | Grant | 616 | — | 4/25/2023 | View on chart |
| WST | ▲ Buy | Grant | 632 | — | 5/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
West Pharmaceutical Services noted in analyst upgrade and market rally
West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.
West Pharmaceutical Services noted in analyst upgrade and market rally. West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.